Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia

To assess the impact of body mass index (BMI) and operative approach on surgical morbidity and costs in patients with endometrial carcinoma (EC) and hyperplasia (EH).All women with BMI data who underwent surgery for EC or EH from 2008 to 2014 were identified from MarketScan, a healthcare claims database. Differences in 30-day complications and costs were compared between BMI groups and stratified by surgical modality.Of 1112 patients, 35%, 36%, and 29% had a BMI of ≤29, 30-39, and ≥40kg/mMIS may increase the value of care by minimizing complications and decreasing costs. This may be most pronounced in morbidly obese women.